Project Grant HT94252510381
Award Date
6/1/25
Completion Date
5/31/28
Dollars Obligated
$885K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
This federal Project Grant award of $3,128,801.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The Leland Stanford Junior University. The grant funding supports the development of a "Blood Test to Measure Sleep Deprivation and Circadian Time" over a 3-year period from June 1, 2025 to May 31, 2028. The goal of this research project is to transform healthcare for military service members and the broader public by...
The Defense Health Agency awarded a $325,650 project grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Geneva Foundation. The grant, awarded on March 1, 2025, will fund a study to assess changes in the human blood proteome following total sleep deprivation. The project will be conducted by The Geneva Foundation, a non-profit organization specializing in biomedical research and medical technology development for federal agencies, including the...
The Department of the Army Medical Command awarded a $384,001 Project Grant to Cold Spring Harbor Laboratory under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2022 to February 29, 2024 to investigate the neural circuit mechanisms of stress-induced insomnia and metabolic dysfunction. Through its support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
The federal Project Grant award of $1,074,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the production of cultured red blood cells for sickle cell disease patient support at Brigham & Women's Hospital Inc., a prominent academic medical center in Boston, Massachusetts. The 4-year grant, with a performance period from June 1, 2025 to May 31, 2029, will fund advanced biomedical...
The Defense Health Agency awarded Brigham & Women's Hospital Inc. a $253,636 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2025 to investigate the role of the secreted factor CTHRC1 in the pathogenesis of tuberous sclerosis complex. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
This $345,800 Project Grant was awarded on May 1, 2024 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The grant supports research on the "Role of Stress Granules in the Pathogenesis and Therapy of Pulmonary Hypertension", with a performance period from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program funds a...
This federal Project Grant award of $1,789,999.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding a novel approach to increase fetal and embryonic hemoglobins for the treatment of sickle cell anemia. The project is being conducted by Brigham & Women's Hospital Inc., a prominent academic medical center and research institution affiliated with Harvard Medical School. The research aims to develop innovative...
The Defense Health Agency awarded a $1,318,799.00 Project Grant to Brigham & Women's Hospital Inc. in Boston, MA on June 15, 2023 under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "THE BRIDGE PROJECT: BROADENING THE REACH OF IMAGING, DIAGNOSTICS, AND GENETIC EVALUATION", will fund research and development to transform healthcare for U.S. military service members and the public through innovative medical solutions for the battlefield and...
This federal Project Grant award of $319,542.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports research at Brigham & Women's Hospital Inc. to investigate the modulation of epigenetic regulators controlling pathogenic astrocytes for the treatment of multiple sclerosis (MS). The research aims to advance scientific understanding and develop innovative therapeutic approaches for this chronic neurological...
The Defense Health Agency awarded a $682,266 Project Grant to Brigham & Women's Hospital Inc. under the Military Medical Research and Development program (CFDA 12.420) on May 15, 2024. The grant supports research to develop targeted endothelial cell-derived extracellular vesicle nanoparticles for immunotherapy against brain cancer, with a performance period ending on May 14, 2026. As a subsidiary of Partners Healthcare System Incorporated, Brigham & Women's Hospital has extensive...